tiprankstipranks
Trending News
More News >

EXACT Therapeutics to Hold Separate Board Candidate Votes at AGM

Story Highlights
EXACT Therapeutics to Hold Separate Board Candidate Votes at AGM

Confident Investing Starts Here:

EXACT Therapeutics AS ( (DE:56F) ) just unveiled an update.

EXACT Therapeutics AS announced that during their upcoming Annual General Meeting, separate votes will be conducted for each board of directors candidate. This decision allows shareholders to submit proxies or advance votes through the VPS or specified forms, ensuring a more tailored voting process. This move could potentially impact the company’s governance and strategic direction by allowing more precise shareholder input.

More about EXACT Therapeutics AS

EXACT Therapeutics is a clinical-stage precision medicine company that focuses on utilizing ultrasound and microbubbles for targeted drug delivery in oncology. Their proprietary Acoustic Cluster Therapy (ACT®) is designed to enhance the delivery of therapeutic agents across various medical conditions, including cancer and brain diseases. The company is publicly traded on Euronext Growth Oslo under the ticker EXTX.

Average Trading Volume: 17,239

Current Market Cap: NOK182.2M

See more insights into 56F stock on TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App